Finerenone May Lower Sudden Death Risk Across the Cardio-Kidney-Metabolic Continuum
Proposed Section Structure
This topic is best addressed through a clinically oriented structure that moves from disease context to pooled trial design, then to risk prediction, treatment effect, interpretation, and implications for practice. The article therefore uses the following sections: Highlights; Background; Study Design and Methods; Key Results; Mechanistic and Clinical Interpretation; Strengths and Limitations; Clinical Implications; Conclusion; Funding and Registration; References.
Highlights
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.